Skip to main content
PPCBD logo

Propanc Biopharma, Inc. (PPCBD) Stock Analysis

DELISTED

What happened to Propanc Biopharma, Inc. (PPCBD) stock?

Propanc Biopharma, Inc. (PPCBD) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
Vol: 139| 52-wk range: $1.50 – $221.56
Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Propanc Biopharma, Inc. (PPCBD). Propanc Biopharma, Inc. is a biopharmaceutical company focused on developing cancer treatments, particularly for pancreatic, ovarian, and colorectal cancers.

Last analyzed: Mar 18, 2026
Propanc Biopharma, Inc. is a biopharmaceutical company focused on developing cancer treatments, particularly for pancreatic, ovarian, and colorectal cancers. Their lead product, PRP, is in the preclinical phase and aims to enhance the anti-cancer effects of multiple enzymes.

Propanc Biopharma, Inc. (PPCBD) Healthcare & Pipeline Overview

Employees1
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Mar 18, 2026

PPCBD OTC Market Information

PPCBD trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

More about this archive record

Can I still buy PPCBD shares?

No. PPCBD stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for PPCBD elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before PPCBD stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Propanc Biopharma, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.